Why the study?
Polycystic ovary syndrome is a common endocrine and metabolic disease, but the roles of long non-coding RNAs in its pathogenesis require clarification.
Does lnc-CCNL1-3:1 overexpression promote granulosa cell apoptosis and suppress glucose uptake in PCOS cell models?
Population
Human luteinized granulosa cells from women with and without PCOS, and KGN cells
Comparison
CCNL overexpression vs control, and silencing FOXO1
Design
In vitro laboratory study
Authors
Loading...
CCNL dysregulation in PCOS hLGCs suggests a pathogenic role; leaves open clinical translation pending prospective validation.
Does lnc-CCNL1-3:1 overexpression promote granulosa cell apoptosis and suppress glucose uptake in PCOS cell models?
lnc-CCNL1-3:1 promotes granulosa cell apoptosis and suppresses glucose uptake by interacting with FOXO1, suggesting it acts as a facilitator in PCOS pathologies such as follicular atresia and insulin resistance.
Huang et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: